Concepedia

Gengjie Yang

GY

22

Publications

2.4K

Citations

18

H-Index

2000

Active since

Affiliations

Incyte (United States)(Current)

Bristol-Myers Squibb (United States)

Experimental Station

Wilmington University

Gengjie Yang is an author at Incyte (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2000–2020

22

Publications

22

Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity

Xiangdong Liu, Niu Shin, Holly K. Koblish et al. · Blood · 2010 · 552 citations · Full text

Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer

Bin-Bing Zhou, Michael Peyton, Biao He et al. · Cancer Cell · 2006 · 375 citations · Full text

, , +7

A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3

Xiangdong Liu, Qian Wang, Gengjie Yang et al. · Clinical Cancer Research · 2011 · 269 citations

Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors

Holly K. Koblish, Michael Hansbury, Kevin Bowman et al. · Molecular Cancer Therapeutics · 2010 · 243 citations · Full text

Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells

Phillip C.C. Liu, Xiangdong Liu, Yanlong Li et al. · Cancer Biology & Therapy · 2006 · 184 citations · Full text

, , +19

Rows per page

1–5 of 22